Class ITerminated · reported 2014-12-24

SOLGAR ENHANCED SERIES ABC DOPHILUS POWDER FOR INFANTS AND CHILDREN, NET WT.

NBTY, Inc. recalled this product and the FDA reported the enforcement action on 24 December 2014 as Class I. The recall was initiated by the firm. NBTY has recalled ABC Dophlius Powder due to the presense of Rhizopus oryzae fungi.

The record

Every field below is published by the FDA in the openFDA food enforcement database. Check the FDA notice before acting on any recall: this page is a reading of the public record, not a substitute for it.

Product
SOLGAR ENHANCED SERIES ABC DOPHILUS POWDER FOR INFANTS AND CHILDREN, NET WT. 1.75 oz (50 g), UPC 0 33984 00010 0. Carefully Manufactured by: Solgar, Inc., 500 Willow Tree Road Leonia, NJ 07605 U.S.A.
UPC
033984000100
Reason for recall
NBTY has recalled ABC Dophlius Powder due to the presense of Rhizopus oryzae fungi.
Recalling firm
NBTY, Inc.
Firm location
Bohemia, New York, United States
Classification
Class I
Status
Terminated
Recall number
F-0710-2015
Quantity
3,183 bottles
Distribution
AL, AR, AZ, CA, CT, CO, FL, IA, IL, IN, MI, ME, MO, MA, NC, NE, NY, NJ, NV, OH, OK, PA, PR, UT, TN, TX, VT, KY, WI, WA, United Kingdom and Israel
Initiated
14 November 2014
Reported by FDA
24 December 2014
Terminated
9 May 2017
Firm notified by
Press Release
Product codes
Lot numbers: 074024-01, 074024-01R1 and 074024-02 Expiration Date: 7/31/15

Reading this record

Five things about this record are not in the record itself, and each one changes how it should be read.

  • Class I means the FDA judged a reasonable probability that the product would cause serious health consequences or death. The class is assigned by an agency health hazard evaluation under 21 CFR 7.41, not by the firm.
  • The firm started this recall itself. Most FDA food recalls are voluntary, and a recall is a food safety plan working rather than failing. The circumstances in which the agency asks for one instead are set out in 21 CFR 7.45.
  • This record is the only one the FDA opened for its recall event, so it covers a single product code.
  • The recall ran for 2.5 years, from 14 November 2014 to termination on 9 May 2017. Termination means the agency judged that all reasonable effort had been made, under 21 CFR 7.55, and it says nothing about whether product remained in circulation.
  • The distribution pattern names 30 states, and the FDA published the enforcement report 6 weeks after the firm began the recall.
  • The product description on this record names no food this site can classify, so it appears on no food-type page. That is a limit of the description rather than of the recall.

Named in the distribution pattern: Alabama, Arkansas, Arizona, California, Connecticut, Colorado, Florida, Iowa, Illinois, Indiana, Michigan, Maine, Missouri, Massachusetts, North Carolina, Nebraska, New York, New Jersey, Nevada, Ohio, Oklahoma, Pennsylvania, Puerto Rico, Utah, Tennessee, Texas, Vermont, Kentucky, Wisconsin, Washington. Those pages count recalls by where the RECALLING FIRM sits, which is a different question from where this product went.

Other records from NBTY, Inc.

The FDA opens one enforcement record per product code, so several of these are frequently one recall event. 5 other records name this firm.

ReportedProductFirmReasonClass
2013-03-27MET-Rx EXTREME NOS PUMPED NITRO-PUNCH Naturally Flavored DIETARY SUPPLEMENT, 20 FL. OZ. (1.25 PT) (591 mL), UPC Code 7 49826 00512 6, Label Revision 05D, Item Number 48515 --- Manufactured in the USA by MET-Rx Nutrition, Inc. Boca Raton, FL 33487NBTY Inc.The color, odor, and taste of the products are changing and do not meet the firm's high quality standards. This is an issue of commercial spoilage.Class III
2013-03-27MET-Rx EXTREME NOS PUMPED DOUBLE BERRY Naturally and Artificially Flavored DIETARY SUPPLEMENT, 20 FL. OZ. (1.25 PT) (591 mL), UPC 7 49826 35909 0, Label Revision 01C, Item Number 35909 (Bottle) Item Number 35910 (case) --- Manufactured in the USA by MET-Rx Nutrition, Inc. Boca Raton, FL 33487NBTY Inc.The color, odor, and taste of the products are changing and do not meet the firm's high quality standards. This is an issue of commercial spoilage.Class III
2013-03-27MET-Rx EXTREME NOS PUMPED WATERMELON Naturally and Artificially Flavored DIETARY SUPPLEMENT, 20 FL. OZ. (1.25 PT) (591 mL), UPC 7 49826 27603 8, Label Revision 02C, Item Number 27603 (Bottle) Item Number 27604 (case) --- Manufactured in the USA by MET-Rx Nutrition, Inc. Boca Raton, FL 33487NBTY Inc.The color, odor, and taste of the products are changing and do not meet the firm's high quality standards. This is an issue of commercial spoilage.Class III
2013-02-13PURE PROTEIN PROTEIN SHOT 25g PROTEIN, GRAPE Flavor PROTEIN DRINK 2.9 fl. oz. (86 mL), Product Number 50451, Bulk Number 36753 (Vial), UPC 7 49826 50451 3 (Vial), and Product Number 50452, Bulk Number 36753 (Carton of 6), UPC 7 49826 50452 0 (Carton). --- Carefully Manufactured by Worldwide Sport Nutritional Supplements, Inc. Bayport, NY 11705NBTY Inc.Lactobacillus plantarum and Lactobacillus brevis were detected in a sample of the product tested by a private laboratory. This is an issue of commercial spoilage.Class III
2013-02-13MET-Rx EXTREME THERMO RAGE WATERMELON DIETARY SUPPLEMENT, 8 FL. OZ. (240 mL) , Product Number 50390 (Bulk number 50389), UPC 7 86560 50389 1, Label Revision 00B --- Manufactured in the USA by MET-RX Nutrition, Inc. Boca Raton, FL 33487NBTY Inc.Acetobacter lovaniensis was detected in a sample of the product tested by a private laboratory. This is an issue of commercial spoilage.Class III

All 6 records for NBTY Inc.

All 2014 recalls · All FDA food recall data

Behind every recall is a clause somebody has to produce evidence for at their next audit. Krolda maps supplier documents to the clause they satisfy in FSSC 22000, IFS Food and 21 CFR 117, and routes the corrective action when the evidence is missing.

Early access

Recall records come from the openFDA food enforcement API, published by the U.S. Food and Drug Administration in the public domain. Krolda adds the hazard classification and the clause mapping; neither is an FDA determination. Always check the FDA notice before acting on a recall.